Skip to main content

Advertisement

Log in

Increased Plasma IL-17F Levels in Rheumatoid Arthritis Patients Are Responsive to Methotrexate, Anti-TNF, and T Cell Costimulatory Modulation

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

The aims of this study are to compare plasma levels of IL17A, A/F, and F biomarkers in RA patients versus controls, and to determine responsiveness to methotrexate (MTX), anti-TNFs, and abatacept. We selected plasma samples from RA cohorts consisting of a cross-sectional RA cohort (N = 78) not receiving DMARDs at the time of sampling, as well as from longitudinal drug start cohorts (N = 71 patients) with pre/post samples including anti-TNF, abatacept, and MTX-treated patients. We assayed IL-17A, IL-17F, and IL17-A/F using a highly sensitive immunoassay system. Plasma levels of IL-17A, IL-17A/F, and IL-17F were all significantly increased in RA versus controls. The difference was largest in IL-17F, with median IL-17F levels in RA patients being approximately 18-fold higher than controls (81 pg/mL in RA vs. 4.4 pg/mL in controls, p < 0.001). Among the forms of IL-17, only IL-17F was decreased after therapy in the MTX cohort (p = 0.006), abatacept cohort (p < 0.001), and anti-TNF cohorts (p = 0.02), whereas IL-17A and IL-17A/F were not significantly decreased for any of the three drug cohorts. Synovial fluid analysis demonstrated higher IL-17F levels in RA (p = 0.016) than healthy controls. These results suggest a specific role for IL-17F in human RA pathogenesis and as a therapeutic target.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

hsCRP:

High sensitivity C-reactive protein

DMARD:

Disease-modifying antirheumatic drug

ELISA:

Enzyme-linked immunosorbent assay

ESR:

Erythrocyte sedimentation rate

IL-1 IL-1B:

Interleukin-1

IL-1B:

Interleukin-1 beta

IL-17:

Interleukin-17

IL-6:

Interleukin-6

IL-6R alpha:

Interleukin 6 receptor alpha

MMP:

Matrix metalloproteinase

MTX:

Methotrexate

OA:

Osteoarthritis

RA:

Rheumatoid arthritis

RANKL:

Receptor activator of nuclear factor kappa-B ligand

sTNFRII:

Soluble tumor necrosis factor receptor 2

TNF:

Tumor necrosis factor

References

  1. Miossec, P., T. Korn, and V.K. Kuchroo. 2009. Interleukin-17 and type 17 helper T cells. The New England Journal of Medicine 361: 888–98.

    Article  CAS  PubMed  Google Scholar 

  2. Pappu, R., V. Ramirez-Carrozzi, and A. Sambandam. 2011. The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology 134: 8–16.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Gaffen, S.L. 2009. The role of interleukin-17 in the pathogenesis of rheumatoid arthritis. Current Rheumatology Reports 11: 365–70.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Hot, A., S. Zrioual, M.L. Toh, et al. 2011. IL-17A- versus IL-17F-induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in rheumatoid synoviocytes. Annals of the Rheumatic Diseases 70: 341–8.

    Article  CAS  PubMed  Google Scholar 

  5. Zrioual, S., R. Ecochard, A. Tournadre, et al. 2009. Genome-wide comparison between IL-17A- and IL-17 F-induced effects in human rheumatoid arthritis synoviocytes. Journal of Immunology 182: 3112–20.

  6. Metawi, S.A., D. Abbas, M.M. Kamal, et al. 2011. Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clinical Rheumatology 30: 1201–7.

    Article  PubMed  Google Scholar 

  7. Chen, D.Y., Y.M. Chen, H.H. Chen, et al. 2011. Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-alpha therapy. Arthritis Research & Therapy 13: R126.

    Article  CAS  Google Scholar 

  8. Yue, C., X. You, L. Zhao, et al. 2010. The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients. Rheumatology International 30: 1553–7.

    Article  CAS  PubMed  Google Scholar 

  9. Zhang, L., J.M. Li, X.G. Liu, et al. 2011. Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. Journal of Clinical Immunology 31: 606–14.

    Article  CAS  PubMed  Google Scholar 

  10. Todd, J., B. Freese, A. Lu, et al. 2007. Ultrasensitive flow-based immunoassays using single-molecule counting. Clinical Chemistry 53: 1990–5.

    Article  CAS  PubMed  Google Scholar 

  11. Wang, T.J., K.C. Wollert, M.G. Larson, et al. 2012. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation 126: 1596–604.

    Article  CAS  PubMed  Google Scholar 

  12. Tarawneh, R., J.M. Lee, J.H. Ladenson, et al. 2012. CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease. Neurology 78: 709–19.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. St Ledger, K., S.J. Agee, M.T. Kasaian, et al. 2009. Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system. Journal of Immunological Methods 350: 161–70.

    Article  CAS  PubMed  Google Scholar 

  14. van Gestel, A.M., M.L. Prevoo, M.A. van’t Hof, et al. 1996. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis and Rheumatism 39: 34–40.

    Article  PubMed  Google Scholar 

  15. Buch, M.H., and P. Emery. 2011. New therapies in the management of rheumatoid arthritis. Current Opinion in Rheumatology 23: 245–51.

    Article  CAS  PubMed  Google Scholar 

  16. Attur, M.G., R.N. Patel, S.B. Abramson, et al. 1997. Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis and Rheumatism 40: 1050–3.

    Article  CAS  PubMed  Google Scholar 

  17. LeGrand, A., B. Fermor, C. Fink, et al. 2001. Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci. Arthritis and Rheumatism 44: 2078–83.

    Article  CAS  PubMed  Google Scholar 

  18. Cua, D.J., and C.M. Tato. 2010. Innate IL-17-producing cells: the sentinels of the immune system. Nature Reviews. Immunology 10: 479–89.

    Article  CAS  PubMed  Google Scholar 

  19. Suurmond, J., A.L. Dorjee, M.R. Boon, et al. 2011. Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium. Arthritis Research & Therapy 13: R150.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work is supported in part by US National Institutes of Health grant R01-AR054817 (S.B.A.). Dr Greenberg received salary support from the NIH (K23AR054412).

Contributions

MJ carried out data analysis, interpretation, and supervised manuscript drafting/revision.

MA supervised data acquisition, interpretation, and manuscript revision.

VF carried out data acquisition.

JT supervised data acquisition, interpretation, and manuscript drafting/revision.

ML carried out data analysis and manuscript drafting/revision.

QL carried out data analysis.

RR generated biomarker results and carried out data analysis.

SA supervised data analysis, interpretation, and manuscript revision.

JG supervised data acquisition, analysis, interpretation, and manuscript revision.

Conflict of Interest

JT, RR, and QL are employees of Singulex, the manufacturer of the assays used in the study. The other authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeffrey D. Greenberg.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 29 kb)

ESM 2

(DOC 31 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jain, M., Attur, M., Furer, V. et al. Increased Plasma IL-17F Levels in Rheumatoid Arthritis Patients Are Responsive to Methotrexate, Anti-TNF, and T Cell Costimulatory Modulation. Inflammation 38, 180–186 (2015). https://doi.org/10.1007/s10753-014-0020-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-014-0020-1

KEY WORDS

Navigation